Good Health Can’t Wait.

Good Health Can’t Wait.
Dr. Reddy’s Laboratories Limited
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(All amounts in Indian Rupees millions, except share data and where otherwise stated)
2.44: ACQUISITION OF SELECT ESTABLISHED BRAND PORTFOLIO OF UCB
On 1 April 2015, the Company entered into a definitive agreement with UCB India Private Limited and other UCB group companies (together referred to
as “ UCB”) to acquire a select portfolio of established products business in the territories of India, Nepal, Sri Lanka and Maldives. The said business was
acquired on a slump sale basis. The transaction includes approximately 350 employees engaged in operations of the India Business. The acquisition is
expected to strengthen the Company’s presence in the areas of Dermatology, Respiratory and Pediatrics. The total purchase consideration was ` 8,000.
The acquisition is expected to be closed in the first quarter of the financial year 2015-16.
2.45: COMPARATIVE FIGURES
Previous year’s figures have been regrouped / reclassified wherever necessary, to conform to current year’s classification.
As per our report of even date attached
for B S R & Co. LLP
Chartered Accountants
for and on behalf of the Board of Directors of Dr. Reddy’s Laboratories Limited
Firm Registration No.: 101248W/W-100022
Supreet Sachdev
Partner K Satish Reddy Chairman
Membership No.: 205385 G V Prasad Co-Chairman & Chief Executive Officer
Place : Hyderabad Saumen Chakraborty President & Chief Financial Officer
Date : 12 May 2015 Sandeep Poddar Company Secretary
220